BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27317936)

  • 1. Early prediction of cisplatin-induced nephrotoxicity by urinary vanin-1 in patients with urothelial carcinoma.
    Hosohata K; Washino S; Kubo T; Natsui S; Fujisaki A; Kurokawa S; Ando H; Fujimura A; Morita T
    Toxicology; 2016 Jun; 359-360():71-5. PubMed ID: 27317936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary vanin-1 as a novel biomarker for early detection of drug-induced acute kidney injury.
    Hosohata K; Ando H; Fujimura A
    J Pharmacol Exp Ther; 2012 Jun; 341(3):656-62. PubMed ID: 22399813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Biomarker for Acute Kidney Injury, Vanin-1, for Obstructive Nephropathy: A Prospective Cohort Pilot Study.
    Washino S; Hosohata K; Oshima M; Okochi T; Konishi T; Nakamura Y; Saito K; Miyagawa T
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791405
    [No Abstract]   [Full Text] [Related]  

  • 4. Early detection of renal injury using urinary vanin-1 in rats with experimental colitis.
    Hosohata K; Ando H; Fujimura A
    J Appl Toxicol; 2014 Feb; 34(2):184-90. PubMed ID: 23307618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity.
    Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M
    Iran J Kidney Dis; 2015 Jul; 9(4):306-10. PubMed ID: 26174458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
    Shoji S; Hosojima M; Kabasawa H; Kondo R; Miura S; Watanabe S; Aoki N; Kaseda R; Kuwahara S; Tanabe N; Hirayama Y; Narita I; Kikuchi T; Kagamu H; Saito A
    BMC Cancer; 2019 Dec; 19(1):1170. PubMed ID: 31791266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting cisplatin-induced acute kidney injury by urinary neutrophil gelatinase-associated lipocalin excretion: a pilot prospective case-control study.
    Gaspari F; Cravedi P; Mandalà M; Perico N; de Leon FR; Stucchi N; Ferrari S; Labianca R; Remuzzi G; Ruggenenti P
    Nephron Clin Pract; 2010; 115(2):c154-60. PubMed ID: 20407275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigations of renal function using the level of neutrophil gelatinase-associated lipocalin associated with single-dose of cisplatin during chemotherapy.
    Maghsoudi O; Mirjalili SH; Dolatabadi M; Joshaghani MF; Zarea M; Yahaghi E; Mokarizadeh A
    Diagn Pathol; 2015 Jul; 10():98. PubMed ID: 26170013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in Urinary Renal Failure Biomarkers in Cancer Patients Initially Treated with Cisplatin.
    Maeda A; Ando H; Ura T; Muro K; Aoki M; Saito K; Kondo E; Takahashi S; Ito Y; Mizuno Y; Fujimura A
    Anticancer Res; 2017 Sep; 37(9):5235-5239. PubMed ID: 28870959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo and In Vitro Evaluation of Urinary Biomarkers in Ischemia/Reperfusion-Induced Kidney Injury.
    Hosohata K; Jin D; Takai S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.
    George B; Joy MS; Aleksunes LM
    Exp Biol Med (Maywood); 2018 Feb; 243(3):272-282. PubMed ID: 29231123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary early kidney injury molecules in children with beta-thalassemia major.
    Şen V; Ece A; Uluca Ü; Söker M; Güneş A; Kaplan İ; Tan İ; Yel S; Mete N; Sahin C
    Ren Fail; 2015 May; 37(4):607-13. PubMed ID: 25656833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of acute kidney injury defined by CTCAE v4.0 during first course of cisplatin-based chemotherapy on treatment outcomes in advanced urothelial cancer patients.
    Ishitsuka R; Miyazaki J; Ichioka D; Inoue T; Kageyama S; Sugimoto M; Mitsuzuka K; Matsui Y; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Kawai K; Nishiyama H
    Clin Exp Nephrol; 2017 Aug; 21(4):732-740. PubMed ID: 27565169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of nephrotoxicity between patients with a solitary-functioning kidney and those with bilateral-functioning kidneys in cisplatin-based chemotherapy for advanced urothelial carcinoma: a Japanese retrospective multi-institutional study.
    Inoue T; Miyazaki J; Ichioka D; Narita S; Kageyama S; Sugimoto M; Mitsuzuka K; Shiraishi Y; Kinoshita H; Wakeda H; Nomoto T; Kikuchi E; Matsui Y; Fujie K; Habuchi T; Nishiyama H
    BMC Cancer; 2018 Mar; 18(1):290. PubMed ID: 29540229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of cisplatin-induced acute kidney injury by recombinant neutrophil gelatinase-associated lipocalin.
    Ma Q; Devarajan SR; Devarajan P
    Ren Fail; 2016 Oct; 38(9):1476-1482. PubMed ID: 27605163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity.
    Mishra J; Mori K; Ma Q; Kelly C; Barasch J; Devarajan P
    Am J Nephrol; 2004; 24(3):307-15. PubMed ID: 15148457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Impact of different methods of estimating renal function on determining eligibility for cisplatin (CDDP)-based chemotherapy in patients with invasive urothelial carcinoma].
    Goto T; Yoshimura K; Matsui Y; Shimizu Y; Inoue T; Okubo K; Kamba T; Nishiyama H; Ogawa O
    Hinyokika Kiyo; 2011 Dec; 57(12):671-6. PubMed ID: 22240299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
    Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
    Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary vanin-1 associated with chronic kidney disease in hypertensive patients: A pilot study.
    Hosohata K; Matsuoka H; Iwanaga K; Kumagai E
    J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1458-1465. PubMed ID: 32869948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
    Waring WS; Moonie A
    Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.